Molecular targeting of malignant pleural mesothelioma by c-Met and ROS modulation

被引：0
|
作者：
Jagadeeswaran, R. [1 ]
Zumba, O. [1 ]
Kindler, H. L. [1 ]
Salgia, R. [1 ]
机构：
[1] Univ Chicago, Chicago, IL 60637 USA
来源：
LUNG CANCER | 2006年 / 54卷
关键词：
D O I：
10.1016/S0169-5002(07)70300-8
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
224
引用
收藏
页码：S54 / S54
页数：1
相关论文
共 50 条
  • [41] Immunotherapy of malignant pleural mesothelioma using MET specific t - cells
    Thayaparan, Thivyan
    von der Stegen, Sjoukje
    Pereira, Ana C. Parente
    Petrovic, Roseanna
    Spicer, James
    Maher, John
    CANCER RESEARCH, 2014, 74 (19)
  • [42] Expression of c-met proto-oncogene product (c-MET) in benign and malignant bone tumors
    Naka, T
    Iwamoto, Y
    Shinohara, N
    Ushijima, M
    Chuman, H
    Tsuneyoshi, M
    MODERN PATHOLOGY, 1997, 10 (08) : 832 - 838
  • [43] Multiple RTK targeting as a therapeutic option in malignant pleural mesothelioma
    Baird, A.
    Easty, D.
    Mohamed, B. M.
    Jarzabek, M.
    Shiels, L.
    Soltermann, A.
    Raeppel, S.
    McDonagh, L.
    Clarke, G.
    Crosbie-Staunton, K.
    Stanfill, B.
    Nonaka, D.
    Goparju, C. M.
    Prina-Mello, A.
    Volkov, Y.
    Murer, B.
    Fennell, D. A.
    O'Donnell, D. M.
    Mutti, L.
    Barr, M. P.
    Finn, S.
    Cuffe, S.
    Pass, H. I.
    Schmitt-Opitz, I.
    Byrne, A.
    O'Byrne, K. J.
    Gray, S. G.
    LUNG CANCER, 2017, 103 : S26 - S26
  • [44] Targeting Anti-Apoptotic Mechanisms in Malignant Pleural Mesothelioma
    Peng, R.
    Schmid, R. A.
    JOURNAL OF THORACIC ONCOLOGY, 2021, 16 (03) : S153 - S153
  • [45] Therapeutic targeting of multiple signaling pathways in malignant pleural mesothelioma
    Mukohara, T
    Civiello, G
    Johnsona, BE
    Jänne, PA
    ONCOLOGY, 2005, 68 (4-6) : 500 - 510
  • [46] Targeting Polyamines for Treatment of Malignant Pleural Mesothelioma in Xenograft Models
    Lam, S. K.
    Yan, S.
    Ho, J. C.
    JOURNAL OF THORACIC ONCOLOGY, 2019, 14 (10) : S762 - S762
  • [47] Molecular prognostic markers in Malignant Pleural Mesothelioma (MPM)
    Bahnassy, Abeer A.
    Gaafar, Rabab M.
    Zekri, Abdel-Rahman N.
    Abdelrahman, Abdelrahman M.
    Aboulkassem, Fatma A.
    Elsherif, Ghada M.
    JOURNAL OF THORACIC ONCOLOGY, 2009, 4 (09) : S757 - S757
  • [48] The Evolving Landscape of the Molecular Epidemiology of Malignant Pleural Mesothelioma
    Lettieri, Sara
    Bortolotto, Chandra
    Agustoni, Francesco
    Lococo, Filippo
    Lancia, Andrea
    Comoli, Patrizia
    Corsico, Angelo G.
    Stella, Giulia M.
    JOURNAL OF CLINICAL MEDICINE, 2021, 10 (05) : 1 - 21
  • [49] Making the Case for Molecular Staging of Malignant Pleural Mesothelioma
    Bueno, Raphael
    SEMINARS IN THORACIC AND CARDIOVASCULAR SURGERY, 2009, 21 (02) : 188 - 193
  • [50] Targeting c-Met in triple negative breast cancer: preclinical studies using the c-Met inhibitor, Cpd A
    Breen, Laura
    Gaule, Patricia B.
    Canonici, Alexandra
    Walsh, Naomi
    Collins, Denis M.
    Cremona, Mattia
    Hennessy, Bryan T.
    Duffy, Michael J.
    Crown, John
    O' Donovan, Norma
    Eustace, Alex J.
    INVESTIGATIONAL NEW DRUGS, 2020, 38 (05) : 1365 - 1372
12345